Disparities among the disadvantaged: variation in lipid management in the Ohio Medicaid program.

Disparities among the disadvantaged: variation in lipid management in the Ohio Medicaid program.
复制标题

弱势群体之间的差异:俄亥俄州医疗补助计划中脂质管理的差异。

DOI:
10.1016/j.ypmed.2005.11.016
复制
发表时间:
2006
期刊:
Preventive medicine.
影响因子:
--
通讯作者:
Aron,DavidC
Aron,DavidC
中科院分区:
--
文献类型:
--
作者:
Litaker,David;Koroukian,Siran;Frolkis,JosephP;Aron,DavidC

文献摘要

相似文献

在心血管疾病(CVD)的预防中存在差异,但其他非临床因素可能会影响治疗,进一步加剧了差异。METHODS使用俄亥俄州医疗补助数据从1992年至1999年,我们确定了一个样本的19,106个人与CVD相关的诊断或程序。对药房索赔的审查确定了降脂药物(包括他汀类药物、贝特类药物和胆汁螯合剂)的既往、新的和长期使用者。2010年TS 3934(20.6%)名医疗补助受益人既往使用过降脂药物,1598(10.5%)名患者提出了新的索赔,5532名既往或新的使用者中有2998名(54.2%)人提出了≥6次补充索赔。60岁以下的少数成年人最不可能是以前的使用者(0.80 [0.67,0.96]),新用户(0.75 [0.58,0.98]),或长期使用降脂药(0.65 [0.49,0.84])。结论:加强少数民族青年接受和长期使用脂质的努力,降低剂可降低与CVD相关的随后发病率和死亡率的风险。
BACKGROUNDRacial disparities exist in cardiovascular disease (CVD) prevention, but other non-clinical factors may influence treatment, further exacerbating disparities.METHODSUsing Ohio Medicaid data from 1992 to 1999, we identified a sample of 19,106 individuals with CVD-related diagnoses or procedures. A review of pharmacy claims identified previous, new, and long-term users of lipid-lowering agents, including statins, fibrates, and bile sequestrants.RESULTS3934 (20.6%) Medicaid beneficiaries used lipid-lowering medications previously, 1598 (10.5%) filed new claims, and 2998 of 5532 (54.2%) previous or new users filed ≥6 claims for refills. Minority adults ≤60 years were least likely to have been previous users (0.80 [0.67, 0.96]), new users (0.75 [0.58, 0.98]), or to use lipid-lowering agents long-term (0.65 [0.49, 0.84]).CONCLUSIONSTargeted efforts to enhance younger minority adults' receipt and long-term use of lipid-lowering agents may reduce risks for subsequent morbidity and mortality related to CVD.